Search alternatives:
significant use » significant cause (Expand Search), significant i.e (Expand Search), significantly used (Expand Search)
mean decrease » a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
use based » rule based (Expand Search), case based (Expand Search), one based (Expand Search)
Showing 61 - 80 results of 126,091 for search '(( significant use based ) OR ( significant ((nn decrease) OR (mean decrease)) ))', query time: 1.21s Refine Results
  1. 61
    S1 Data -

    S1 Data - by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 62
    Sociodemographic characteristics of the participants.

    Sociodemographic characteristics of the participants. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 63
    Summary of BFI traits as described by Sattler and Schunck.

    Summary of BFI traits as described by Sattler and Schunck. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 64
    Factors associated with personality traits.

    Factors associated with personality traits. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 65
    Map of Zimbabwe highlighting the districts detected as persistent hotspots of <i>S. haematobium</i> prevalence (PPHS), persistent hotspots of decreased praziquantel efficacy (EPHS), and districts of both PPHS and EPHS.

    Map of Zimbabwe highlighting the districts detected as persistent hotspots of <i>S. haematobium</i> prevalence (PPHS), persistent hotspots of decreased praziquantel efficacy (EPHS)... by Takafira Mduluza (39754)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    The framework of model parameter estimation based on GLUE and different combinations of observed data in this work.

    The framework of model parameter estimation based on GLUE and different combinations of observed data in this work. by Yonghui Zhang (279832)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 67
    S4 NIRS data for control and S4 NIRS data for rTMS.

    S4 NIRS data for control and S4 NIRS data for rTMS. by Nakako Okamoto (18501452)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 68
    Experimental procedure.

    Experimental procedure. by Nakako Okamoto (18501452)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 69
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 70
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 72
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 74
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 75
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 76
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 77
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 78
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 79
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 80
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: